WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011158039) UREIDO-PYRAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF RESPIRATORY SYNCITIAL VIRUS (RSV) INFECTION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/158039    International Application No.:    PCT/GB2011/051136
Publication Date: 22.12.2011 International Filing Date: 17.06.2011
IPC:
A61P 31/16 (2006.01), A61P 11/00 (2006.01), A61P 11/06 (2006.01), A61P 31/00 (2006.01)
Applicants: RESPIVERT LIMITED [GB/GB]; 50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG (GB) (For All Designated States Except US).
CASS, Lindsey [GB/GB]; (GB) (For US Only).
ITO, Kazuhiro [JP/GB]; (GB) (For US Only).
RAPEPORT, William Garth [GB/GB]; (GB) (For US Only).
STRONG, Peter [GB/GB]; (GB) (For US Only)
Inventors: CASS, Lindsey; (GB).
ITO, Kazuhiro; (GB).
RAPEPORT, William Garth; (GB).
STRONG, Peter; (GB)
Agent: TEUTEN, Andrew; Sagittarius IP Taylor House 39 High Street Marlow Buckinghamshire SL7 1AF (GB)
Priority Data:
1010193.9 17.06.2010 GB
PCT/GB2010/052066 10.12.2010 GB
Title (EN) UREIDO-PYRAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF RESPIRATORY SYNCITIAL VIRUS (RSV) INFECTION
(FR) DÉRIVÉS D'URÉIDO-PYRAZOLE DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT D'INFECTIONS PAR UN RHINOVIRUS
Abstract: front page image
(EN)Medicinal use The disclosure relates to compounds of formula (I) for use in the treatment or prophylaxis of respiratory syncitial virus (RSV) infection in particular viral exacerbation of a respiratory disorder such as bronchitis, asthma,COPD and/or cystic fibrosis, methods of treating or preventing RSV infection employing said compounds or pharmaceutical composition comprising the same.
(FR)La présente invention concerne des composés de formule (I) destinés à être utilisés dans le traitement ou la prophylaxie d'une infection par le virus respiratoire syncytial (VRS), en particulier de l'exacerbation virale d'un trouble respiratoire tel qu'une bronchite, l'asthme, une BPCO et/ou la mucoviscidose, des procédés de traitement ou de prévention d'une infection par le VRS utilisant lesdits composés ou des compositions pharmaceutiques les comprenant.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)